215 related articles for article (PubMed ID: 27107518)
1. Early pathologic amyloid induces hypersynchrony of BOLD resting-state networks in transgenic mice and provides an early therapeutic window before amyloid plaque deposition.
Shah D; Praet J; Latif Hernandez A; Höfling C; Anckaerts C; Bard F; Morawski M; Detrez JR; Prinsen E; Villa A; De Vos WH; Maggi A; D'Hooge R; Balschun D; Rossner S; Verhoye M; Van der Linden A
Alzheimers Dement; 2016 Sep; 12(9):964-976. PubMed ID: 27107518
[TBL] [Abstract][Full Text] [Related]
2. Individual Correspondence of Amyloid-β and Intrinsic Connectivity in the Posterior Default Mode Network Across Stages of Alzheimer's Disease.
Pasquini L; Benson G; Grothe MJ; Utz L; Myers NE; Yakushev I; Grimmer T; Scherr M; Sorg C;
J Alzheimers Dis; 2017; 58(3):763-773. PubMed ID: 28482640
[TBL] [Abstract][Full Text] [Related]
3. Early functional connectivity deficits and progressive microstructural alterations in the TgF344-AD rat model of Alzheimer's Disease: A longitudinal MRI study.
Anckaerts C; Blockx I; Summer P; Michael J; Hamaide J; Kreutzer C; Boutin H; Couillard-Després S; Verhoye M; Van der Linden A
Neurobiol Dis; 2019 Apr; 124():93-107. PubMed ID: 30445024
[TBL] [Abstract][Full Text] [Related]
4. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
[TBL] [Abstract][Full Text] [Related]
5. Increased soluble amyloid-beta causes early aberrant brain network hypersynchronisation in a mature-onset mouse model of amyloidosis.
Ben-Nejma IRH; Keliris AJ; Daans J; Ponsaerts P; Verhoye M; Van der Linden A; Keliris GA
Acta Neuropathol Commun; 2019 Nov; 7(1):180. PubMed ID: 31727182
[TBL] [Abstract][Full Text] [Related]
6. Effects of Beta-Amyloid on Resting State Functional Connectivity Within and Between Networks Reflect Known Patterns of Regional Vulnerability.
Elman JA; Madison CM; Baker SL; Vogel JW; Marks SM; Crowley S; O'Neil JP; Jagust WJ
Cereb Cortex; 2016 Feb; 26(2):695-707. PubMed ID: 25405944
[TBL] [Abstract][Full Text] [Related]
7. Early brain connectivity alterations and cognitive impairment in a rat model of Alzheimer's disease.
Muñoz-Moreno E; Tudela R; López-Gil X; Soria G
Alzheimers Res Ther; 2018 Feb; 10(1):16. PubMed ID: 29415770
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Yanagisawa D; Amatsubo T; Morikawa S; Taguchi H; Urushitani M; Shirai N; Hirao K; Shiino A; Inubushi T; Tooyama I
Neuroscience; 2011 Jun; 184():120-7. PubMed ID: 21497641
[TBL] [Abstract][Full Text] [Related]
9. Bidirectional relationship between functional connectivity and amyloid-β deposition in mouse brain.
Bero AW; Bauer AQ; Stewart FR; White BR; Cirrito JR; Raichle ME; Culver JP; Holtzman DM
J Neurosci; 2012 Mar; 32(13):4334-40. PubMed ID: 22457485
[TBL] [Abstract][Full Text] [Related]
10. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
11. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
12. Impairments of neural circuit function in Alzheimer's disease.
Busche MA; Konnerth A
Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377723
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of the radioiodinated imidazo[1,2-a]pyridine derivative DRK092 for amyloid-β imaging in mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Morimoto Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Suhara T; Higuchi M; Yamada K; Ji B
Neurosci Lett; 2014 Oct; 581():103-8. PubMed ID: 25172571
[TBL] [Abstract][Full Text] [Related]
14. Complex interplay between brain function and structure during cerebral amyloidosis in APP transgenic mouse strains revealed by multi-parametric MRI comparison.
Grandjean J; Derungs R; Kulic L; Welt T; Henkelman M; Nitsch RM; Rudin M
Neuroimage; 2016 Jul; 134():1-11. PubMed ID: 27033685
[TBL] [Abstract][Full Text] [Related]
15. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
[TBL] [Abstract][Full Text] [Related]
16. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
[TBL] [Abstract][Full Text] [Related]
17. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
[TBL] [Abstract][Full Text] [Related]
18. Oral Administration of Thioflavin T Prevents Beta Amyloid Plaque Formation in Double Transgenic AD Mice.
Sarkar S; Raymick J; Ray B; Lahiri DK; Paule MG; Schmued L
Curr Alzheimer Res; 2015; 12(9):837-46. PubMed ID: 26510980
[TBL] [Abstract][Full Text] [Related]
19. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
